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Background: Laparoscopic repair of ventral and incisional hernias has gained popularity since many studies have
reported encouraging results in terms of outcomee and recurrence. Choice of mesh and fixation methods are
considered crucial issues in preventing recurrences and complications. Lightweight meshes are considered the first
choice due to their biomechanical properties and the ability to integrate into the abdominal wall. Titanium helicoidal
tacks still represent the “gold standard” for mesh fixation, even if they have been suggested to be involved in the
genesis of post-operative pain and complications. Recently, absorbable tacks have been introduced, under the
hypothesis that there will be no need to maintain a permanent fixation device after mesh integration. Nevertheless,
there is no evidence that absorbable tacks may guarantee the same results as titanium tacks in terms of strength of
fixation and recurrence rates. The primary end point of the present trial is to test the hypothesis that absorbable tacks
are non-inferior to titanium tacks in laparoscopic incisional and ventral hernia repair (LIVHR) by lightweight polypropylene
mesh, in terms of recurrence rates at 3-year follow-up. Surgical complications, post-operative stay, comfort and pain are
secondary end points to be assessed.
Methods/Design: Two hundred and twenty patients with ventral hernia will be randomized into 2 groups:
Group A (110) patients will be submitted to LIVHR by lightweight polypropylene mesh fixed by titanium tacks;
Group B (110) patients will be submitted to LIVHR by lightweight polypropylene mesh fixed by absorbable tacks.
Discussion: A few retrospective studies have reported similar results when comparing absorbable versus
non-absorbable tacks in terms of intraoperative and early post-operative outcomes. These studies have the pitfalls
to be retrospective evaluation of small series of patients, and the reported results still need to be validated by
larger series and prospective studies.
The aim of the present trial is to investigate and test the non-inferiority of absorbable versus non-absorbable
tacks in terms of hernia recurrence rates, in order to assess whether the use of absorbable tacks may achieve the
same results as non-absorbable tacks in mid-term and long-term settings.
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During the past 50 years, incisional and ventral hernia
repair surgery has evolved from direct suture repair to
the use of synthetic mesh to obtain a tension-free repair
[1–3]. Finally, the tension-free concepts have been ap-
plied to laparoscopic surgery. Laparoscopic repair of in-
cisional/ventral hernias (LIVHR) has gained increasing
popularity, since many studies, included three meta-
analyses, have reported encouraging results in terms of
wound infection, hospital stay and post-operative pain,
and recurrence rates comparable with the open ap-
proach [1–8].
Besides patient selection (age, sex, comorbidities, obes-
ity, hernia site and size, eventual recurrence and type of
previous abdominal surgery) and patient compliance, the
choice of the mesh (bio-materials, size and shape) and
fixation methods (titanium tacks, absorbable tacks, fibrin
glue) are considered crucial issues to achieve optimal re-
sults and reduce complication and recurrence rates
[4,5,9–12]. Lightweight meshes are often considered the
first choice for hernia repair by many authors, since the
evidence that the decreased density of the non-absorbable
material could reduce the “foreign-body response,” im-
prove abdominal wall compliance, cause less shrinkage
and enhance the integration in host tissues [13–15]. Ti-
tanium helicoidal tacks are still considered the “gold
standard” for mesh fixation [16–20]. However, several
complications caused by these tacks have been reported
(adhesion formation and bowel perforation). Further-
more, these devices may be involved in the genesis of
some post-operative pain. Recently, absorbable tacks
have been introduced [21] in combination with light-
weight meshes, under the assumption that permanent
fixation is no longer needed after the mesh is integrated
within host tissues, potentially avoiding some of the
above-described tack-related complications. Neverthe-
less, the efficacy of the use of absorbable tacks has never
been compared to titanium tacks in a prospective analysis:
only a few observational studies report similar results dur-
ing a mid-term post-operative follow-up [21–23].
The Italian Society of Endoscopic Surgery recently car-
ried out a Consensus Conference with a systematic lit-
erature search on this topic and concluded that “mesh
fixation with spiral tacks should be considered the stand-
ard method of fixation in laparoscopic ventral/incisional
hernia repair” and that “there is not enough evidence to
make any recommendation in favor or against the use ofthe absorbable fixing devices” [24]. Also, the International
Endohernia Society published its evidence-based guide-
lines and came to similar conclusions. Both guideline
panels found very little literature about the role of ab-
sorbable fixing devices and stressed the need for further
research about it [25]. In fact, the current evidence on
the use, safety and efficacy of absorbable tacks for mesh
fixation is still based on few retrospective studies giving
inconclusive results [21,22], and a recent report from a
National Register [26], which concludes that the use of
absorbable tacks is related to an increased risk of hernia
recurrence. The latter deals with a very large number of
patients but does not provide any information either
about the type of mesh or the specific kind of tacks used.
The absence of this crucial information limits the useful-
ness of the study. The direct comparison of absorbable
tacks with the current “gold standard,” represented by ti-
tanium tacks appears to be the best way to assess their
efficacy and safety.
Our study primary objective is to determine if absorb-
able tacks are non-inferior to titanium tacks for light-
weight mesh fixation during LIVHR in the end point of
recurrence rate, considering a follow-up of 3 years.
The secondary objectives are to evaluate the possible
superiority of the absorbable tacks in improving post-
operative stay, complications, pain and comfort.
Our choice of a non-inferiority trial design was based
on the assumption that some of the complications re-
lated to the use of metal spiral tack could be avoided by
the use of absorbable devices if their non-inferiority to
the reference treatment (metal tacks) is demonstrated.
This protocol has been prepared in accordance with
Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) [27] and the Consolidated
Standards of Reporting Trials (CONSORT 2010) [28],
taking into accounts its Extension for Nonpharmacolo-
gic Treatment Interventions [29] and the CONSORT
Statement for Reporting Noninferiority and Equivalence
Trials [30].
Methods/Design
Trial design, locations and organizational structure
The TACS trial is a multicentric prospective randomized
study. It will involve five surgical units having extensive
experience in both metallic and absorbable tacks for
LIVHR (this means that each surgeon participating in
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per year with the devices used in the study).
The Reference Center (General Surgery Unit, ICOT
Hospital, Latina, Italy) will coordinate the study and han-
dle the data analysis and interim evaluations.
The study will develop according to the Helsinki Declar-
ation. It obtained the Ethical Committee approval (Inde-
pendent Ethical Committee “Lazio 2”) on 26 May 2014
prior to registration (reference number asl_lt/15675/A001/
2014).Study population and eligibility criteria
All consecutive patients referred to the involved surgi-
cal units will be checked to determine eligibility, by
one dedicated team member, according to the inclusion
and exclusion criteria specified in an additional file
(see Additional file 1).
All the eligible patients will be consecutively enrolled
in the study until the sample size of 220 patients is
reached. The included patients will be divided into two
groups:
Group A: patients submitted to LIVHR by lightweight
polypropylene mesh fixed by titanium helicoidal tacks
(control group);
Group B: patients submitted to LIVHR by lightweight
polypropylene mesh fixed by absorbable tacks (study
group).
Each patient will be introduced to the trial by a mem-
ber of the research group and receive an explanation of
the study protocol (including random assignment of the
fixation device that will be used during surgery). A spe-
cific informed consent regarding participation in the
trial, randomization and explanation of the laparoscopic
hernia repair, with no disclosure about the fixation de-
vice will be obtained and signed before enrolling in the
study.Randomization, allocation concealment, and blinding
A simple 1:1 allocation ratio randomization (without any
restriction) will be guaranteed by an on-line computerized
random generator. Patients will be randomly assigned to
either Group A or Group B in the operating room, just be-
fore surgery.
Patients will be kept blind to the allocation status. Fur-
thermore, post-operative controls will be performed at
each center by a physician not directly involved in the
study. He will be kept blind to the particular device used
on each patient. Due to the nature of the intervention,
the operating staff cannot be blinded to allocation but
will be instructed not to disclose the allocation status of
the participant at any time.Intervention, preoperative and post-operative management
All patients will be assessed preoperatively by clinical
examination and abdominal computed tomography (CT)
or ultrasound (US) scan to evaluate the size and number
of the defect(s).
The devices used in the study (meshes and tacks) will
be:
Physiomesh™ (Ethicon Endo-Surgery, Johnson & Johnson,
Inc.), a lightweight polypropylene mesh with double face
absorbable layer engineered to be placed on the
peritoneal surface
Protack™ (Covidien Surgical, Mansfield, MA, USA),
permanent titanium helicoidal tacks
Securestrap™ (Ethicon Endo-Surgery, Johnson &
Johnson, Inc.), “U”-shaped absorbable tacks made by
polydioxanone, completely resorbed by hydrolysis
within 12–18 months after implantation
All the procedures will be carried out using the same
surgical technique, already described in previous studies
[22,23]. In particular, there will be careful adhesiolysis of
the entire abdominal wall, a search for additional de-
fects, overlapping the defect for at least 3 cm on each
side, setting the tacks at the distance of 1.5 cm in a
double crown configuration [31] and no use of trans-
fixed sutures or glue. After surgery, compressive dressing
will be placed for 4 weeks.
Each surgeon will be provided with a precise descrip-
tion of the standardized technique and a checklist of the
aforementioned necessary technical items to be con-
trolled, filled for every patient and turned back to the
Reference Center. Adherence to the protocol will be
assessed by review of the procedure videos: all centers
will share the videos with the Reference Center. The
operations performed by the Reference Center will be
examined by the primary surgeon of another participat-
ing center who will check that all items on the checklist
have been correctly performed.
A member of the operating team will note the patients
and intervention characteristics in an online database in-
cluding the following parameters:
Patient characteristics (sex, age, comorbidities, personal
therapy)
Hernia features (location and size)
Mesh size
Type of tacks (absorbable/non-absorbable)
Number of tacks used
Operating time
Post-operative hospital stay
Post-operative complications during the index admis-
sion (according to the Clavien-Dindo classification) [32].
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Scale (VNS) for pain classification) [33].
Pain management (use of analgesic drugs).
There will be no difference in preoperative or post-
operative care between the two groups. All patients will
receive 1 dose (1 g) of paracetamol given intravenously
at surgery and 2 more, each at 8-hour interval. Add-
itional need for pain management will be noted on the
records. The follow-up will be scheduled as follows:
1 week (clinical evaluation)
4 weeks (clinical evaluation)
6 months (clinical evaluation or phone interview)
12 months (phone call and eventual clinical evaluation)
24 months after surgery (phone call and eventual
clinical evaluation)
36 months after surgery (phone call and eventual
clinical evaluation)
During the follow-up, hernia recurrence (with eventual
imaging studies) and post-operative complications will be
checked. The following data will be also evaluated, using
the licensed Carolinas Comfort Scale (CCS) [34,35]:
Pain (during resting, during daily activities, during
walking, during exercise):
Pain control by use of analgesic drugs (which kind of
drug, which dosage)
Pain at physical examinationOutcome parameters
The primary end point of the study is:
comparison of the results of the use of metallic and
absorbable tacks to fix lightweight polypropylene
meshes during LIVHR, in terms of hernia recurrence,
to test the hypothesis of non-inferiority of absorbable
tacks when compared to titanium tacks.
The endpoint will be measured by the recurrence rate
at 3 years; interim evaluations will be done at 1-year and
2-year follow-up.
The secondary end point is:
comparison of intraoperative and early post-operative
outcomes, in terms of surgical complications, post-
operative stay, comfort and pain
The comfort and pain parameters will be measured
using the licensed CC S; surgical complications will be
evaluated by the Clavien-Dindo classification [32] and
on the basis of reoperation and readmission rates (1–2
and 3 years).Statistical methods
The sample size calculation is based on the primary end
point. A sample size of 110 in each group permits the
achievement of a study power of 80 %, to detect a non-
inferiority margin difference between the devices used.
The reference group proportion is 0.07. The treatment
group proportion is assumed to be 0.13 under the null
hypothesis of inferiority. The statistic test used will be
the one-sided Z test (unpooled). The significance level of
the test will be targeted at 0.05.
The same sample size will also be adequate to evaluate
the secondary endpoints.
Statistical analysis will be performed at 1, 2 and 3 years
after the first patient’s enrollment by a statistician affili-
ated with the Reference Center.
Dissemination policy
The results of the TACS trial will be presented at inter-
national medical meetings concerning the corresponding
fields of interest. Publications are planned in surgical sci-
entific journals. The results will be disseminated regardless
of the magnitude or direction of the measured effects.
Good clinical practice and ethical approval
The study will develop according to the Helsinki Declar-
ation. It obtained the Ethical Committee approval (Inde-
pendent Ethical Committee “Lazio 2”) on 26 May 2014
prior to registration (reference number asl_lt/15675/
A001/2014). Any modifications to the protocol that may
impact on the conduct of the study, potential benefit to
the patient or may affect patient safety will require a for-
mal amendment to the protocol and a new approval of
the Ethical Committee according to local regulations.
Discussion
In recent years, lightweight meshes have been proposed
for the treatment of abdominal wall hernias, both in
open and laparoscopic repair, to reduce the mesh-related
and/or mesh fixation-related complications [13]. Decreas-
ing the density of non-absorbable material, a reduced “for-
eign-body response” has been demonstrated. This results
in an improved abdominal wall compliance and less mess
shrinkage, thus allowing a better integration of the mesh
in the host tissues [14,15].
This “lightweight approach” is also based on the re-
sults of studies concerning the abdominal wall biomech-
anics [36–39].
Among the large number of meshes and materials uti-
lized for LIVHR, macropore lightweight polypropylene
has been demonstrated to be more efficient than other
materials in terms of inflammatory response and mesh
integration in host tissues [38–42].
A crucial issue in LIVHR is the choice of the mesh fix-
ation method. Titanium helicoidal tacks are most frequently
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antee excellent fixation strength [46] but remain in the
body permanently, and have been associated with severe
complications. Dense adhesion formation, erosion of tacks
in hollow viscera and the formation of so-called "tack her-
nias” have been reported [16,17,47]. However, the most
clinically relevant negative aspect appears to be the in-
creased acute and chronic post-operative pain, as reported
by several studies [22,23,40–42]. Furthermore, permanent
fixation devices seem not to be necessary while using
lightweight macropore meshes, as they become integrated
into the abdominal wall and may not need to be perman-
ently secured [22,23]. Nevertheless, titanium tacks remain
the most common fixation device for LIVHR [47,48]. Re-
cently, absorbable tacks have been introduced [21] to im-
prove biocompatibility, reduce the risk of endoperitoneal
adhesions due to the presence of metallic tacks, and re-
duce mid-term and long-term post-operative pain. The ra-
tionale for the use of absorbable tacks in LIVHR for
lightweight macropore mesh fixation is mainly the bio-
mechanical mesh features since the integration of these
prostheses into the abdominal wall may not need perman-
ent fixation devices. To date, only 2 studies dealing with
the clinical use of absorbable tacks with lightweight mesh
have been published [21,22]. They report similar intraop-
erative and early post-operative outcomes when compar-
ing absorbable and non-absorbable tacks [22]. However,
these are observational studies on small series of patients,
and the reported results still need to be validated.
The aim of the present trial is to compare the results
of the use of metallic and absorbable tacks to fix light-
weight polypropylene meshes during LIVHR, in terms of
hernia recurrence, in order to test the hypothesis the
non-inferiority of absorbable tacks when compared to ti-
tanium tacks.
Furthermore, the authors will compare acute and
chronic post-operative pain after the use of titanium and
absorbable tacks.
If the non-inferiority of the absorbable fixation devices
was assessed, their use could be encouraged and their pos-
sible advantages in terms of reduction of complications
and post-operative pain could be further investigated.Trial registration and protocol version
Primary registry and trial identifying number: Clinical
Trials.gov NCT02076984.
Date of registration in the primary registry: 5 June 2014.
Protocol version: version 1.1 issued on 20 January 2015.Trial status
Patient enrollment started on 1 June 2014 after tEthical
Committee approval.Additional file
Additional file 1: Table showing inclusion and exclusion criteria for
eligibility in the study.
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